Skip to content
Screener

PAR Technology PAR Contingent consideration fair value adjustment

Contingent consideration fair value adjustment at other companies

Insmed logo
InsmedINSM
-$46.96M-357%
Blackrock logo
BlackrockBLK
$180M+2,100%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
-$622K—
Lifetime Brands logo
Lifetime BrandsLCUT
$0—
Lifetime Brands logo
Lifetime BrandsLCUT
$0—
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$0—

Segments

By segment

See full
Reportable Segment$0—

Other financials

Income statement

See full
Revenue$133.4M+18.7%
Gross profit$56.6M+11.0%
Operating income-$12.9M+25.5%
Net income-$16.9M+19.7%
EPS (diluted)-$0.41+21.2%

Balance sheet

See full
Cash & equivalents$91.5M-11.0%
Total debt$431.5M+7.8%
Total equity$813.8M-5.3%
Total assets$1.4B-1.6%

Cash flow

See full
Operating cash flow-$16.6M+3.1%
CapEx$456.0K-41.7%
Free cash flow-$17.0M+3.5%

Valuation

See full
Market cap$734.59M-61.2%
Enterprise value$1.07B-51.0%
P/S1.5×-3.1×

Profitability

See full
Gross margin42.2%-2.6pp
Operating margin-12.6%-2.0pp
Net margin-14.5%-3.3pp
FCF margin-14.3%-4.0pp

Returns & leverage

See full
Return on equity-8.6%-1.9pp
Debt / equity0.5×+0.1×
Current ratio2.2×+0.5×